ANBC INC
Shanghai Yutong Pharma, Inc. engages in the development, manufacturing, and commercialization of traditional Chinese herbal medicines and biological pharmaceuticals in the People's Republic of China. Its products primarily include Qilisheng a product formulated to be a general health enhancer by fortifying the immune system; Qi-ju-di-huang, an oral solution that protects the kidney and the liver;… Read more
ANBC INC (SYUP) - Total Assets
Latest total assets as of December 2007: $6.28 Million USD
Based on the latest financial reports, ANBC INC (SYUP) holds total assets worth $6.28 Million USD as of December 2007.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
ANBC INC - Total Assets Trend (2004–2017)
This chart illustrates how ANBC INC’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
ANBC INC - Asset Composition Analysis
Current Asset Composition (December 2017)
ANBC INC's total assets of $6.28 Million consist of 83.1% current assets and 16.9% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 3.0% |
| Accounts Receivable | $1.69 Million | 63.2% |
| Inventory | $453.44K | 17.0% |
| Property, Plant & Equipment | $450.67K | 16.9% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2004–2017)
This chart illustrates how ANBC INC's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: ANBC INC's current assets represent 83.1% of total assets in 2017, an increase from 14.7% in 2004.
- Cash Position: Cash and equivalents constituted 3.0% of total assets in 2017, down from 4.6% in 2004.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2004.
- Asset Diversification: The largest asset category is accounts receivable at 63.2% of total assets.
ANBC INC Competitors by Total Assets
Key competitors of ANBC INC based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
ANBC INC - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - ANBC INC generates 1.18x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Excellent ROA - For every $100 in assets, ANBC INC generates $ 48.57 in net profit.
ANBC INC - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.26 | 0.26 | 0.26 |
| Quick Ratio | 0.24 | 0.24 | 0.24 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-3.39 Million | $ -3.15 Million | $ -3.15 Million |
ANBC INC - Advanced Valuation Insights
This section examines the relationship between ANBC INC's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 61.3% |
| Total Assets | $2.67 Million |
| Market Capitalization | $46.11 USD |
Valuation Analysis
Below Book Valuation: The market values ANBC INC's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: ANBC INC's assets grew by 61.3% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for ANBC INC (2004–2017)
The table below shows the annual total assets of ANBC INC from 2004 to 2017.
| Year | Total Assets | Change |
|---|---|---|
| 2017-12-31 | $2.67 Million | +61.29% |
| 2016-12-31 | $1.66 Million | +70.08% |
| 2015-12-31 | $974.22K | -84.49% |
| 2007-12-31 | $6.28 Million | +0.43% |
| 2006-12-31 | $6.25 Million | +28.14% |
| 2005-12-31 | $4.88 Million | -15.00% |
| 2004-12-31 | $5.74 Million | -- |